Drawing for LYNSIGHT

USPTO serial 79409301

LYNSIGHT

Reviewed by CopyMark Law Group

Reg. 8172693Status 700Registered
Filing date
Status date
Registration date
Mar 17, 2026
Examiner
KAPLAN, VALERIE ELIZABETH
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with LYNSIGHT?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeff Goehring

Jeff Goehring Nixon & Vanderhye P.C.901 N. Glebe Road, Suite 1100Arlington, VA 22203United States

Goods and services

ClassDescriptionStatusFirst use
009Scientific research and laboratory apparatus, namely, scientific laboratory research instruments for detecting Lynch syndrome or other inherited disorder that increases the risk of developing cancer; educational apparatus and simulators, namely, medical training simulators; equipment and instruments for scientific laboratory research, namely, scientific laboratory research instruments for detecting Lynch syndrome or other inherited disorder that increases the risk of developing cancer and or for DNA analysisACTIVE—
010Diagnostic apparatus for medical purposes for detecting Lynch syndrome or other inherited disorder that increases the risk of developing cancer; Medical and veterinary apparatus and instruments, namely, medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; Surgical apparatus and instruments; Medical imaging apparatus; Tools for medical diagnostics namely, medical specimen collection kits comprised primarily of containers for skin-biopsy samples and printed instructions sold as a unit for medical diagnostic purposes; Diagnostic, examination, and monitoring equipment, namely, medical diagnostic apparatus for detecting Lynch syndrome or other inherited disorder that increases the risk of developing cancer, and medical devices for collecting, storing, and transporting skin-biopsy samples for medical diagnostic testing; Diagnostic apparatus for medical purposes used in medical laboratories, namely, medical specimen collection kits for diagnostic purposes comprised primarily of biopsy sample containers, sterile dressings, and printed instructionsACTIVE—
042Medical research laboratories; Medical and pharmacological research services; DNA screening for scientific research purposes; Natural science services, namely, scientific research; Scientific laboratory services; Consultancy relating to laboratory testing for research purposes; Product development of diagnostic apparatusACTIVE—
044Medical diagnostic services, medical testing and medical analysis for diagnostic purposes; Medical analysis services for diagnostic purposes provided by medical laboratories; Medical and healthcare services; Medical and health services relating to DNA, genetics and genetic testing; Medical analysis services relating to DNA, genetics and genetic testing; Medical screening; DNA screening for medical purposes; Medical treatment services; Medical clinic services; Genetic testing for medical purposes; Medical evaluation services; Medical imaging services; Medical laboratory services for the analysis of samples taken from patients for diagnostic and treatment purposes; Medical consultationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 10, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 22, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 21, 2026FIMPFINAL DISPOSITION PROCESSED—
Jun 17, 2026FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Apr 30, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Apr 13, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Apr 13, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Mar 17, 2026NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Mar 17, 2026R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 27, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 27, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 21, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 2, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 21, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 21, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 21, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 7, 2025RFNTREFUSAL PROCESSED BY IB—
May 22, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
May 22, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 27, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 26, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 20, 2025DOCKASSIGNED TO EXAMINER—
Nov 15, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 15, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 14, 2024REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance